Skip to main content
HROWHealthcare

Harrow Inc (HROW) Insider Trading

In the last 90 days, 1 Harrow Inc (HROW) insider reported no open-market purchases and 1 sale totaling $450,000. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 14, 2026Amir ShojaeiCHIEF SCIENTIFIC OFFICERSale11,250$40.00$450,000
May 18, 2026Adrienne L GravesCorporate insiderOpen Market Purchase1,000$31.07$31,070
May 18, 2026Lauren P SilvernailCorporate insiderOpen Market Purchase1,000$31.00$31,000
May 14, 2026Mark L BaumCHIEF EXECUTIVE OFFICEROpen Market Purchase10,000$30.20$302,000
May 14, 2026Andrew R. BollPRESIDENT AND CFOOpen Market Purchase3,500$29.90$104,650

Common questions

HROW insider trading FAQ

Are HROW insiders buying or selling?
Over the last 90 days, HROW insiders were net sellers, reporting $0.00 of open-market purchases and $450,000 of sales.
When was the last HROW insider purchase?
No open-market insider purchase of Harrow Inc stock was reported in the last 90 days.
Where does HROW insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Harrow Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.